EUVIMEDEUVIMED entdecken
Crossref

Retraction of: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells

Carcinogenesis · 30.10.2026

DOI: 10.1093/carcin/bgag072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis, online erschienen am 30.10.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Retraction of: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis. https://doi.org/10.1093/carcin/bgag072

Vancouver

Retraction of: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis. 2026. doi:10.1093/carcin/bgag072

BibTeX
@article{euvimed2026,
  title = {Retraction of: Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells},
  journal = {Carcinogenesis},
  year = {2026},
  doi = {10.1093/carcin/bgag072}
}
Kostenlos starten →